AC Immune SA
NASDAQ:ACIU

Watchlist Manager
AC Immune SA Logo
AC Immune SA
NASDAQ:ACIU
Watchlist
Price: 3.7 USD 1.93% Market Closed
Market Cap: $366.1m

Wall Street
Price Targets

ACIU Price Targets Summary
AC Immune SA

Wall Street analysts forecast ACIU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACIU is 9.86 USD with a low forecast of 8.08 USD and a high forecast of 12.6 USD.

Lowest
Price Target
8.08 USD
118% Upside
Average
Price Target
9.86 USD
166% Upside
Highest
Price Target
12.6 USD
241% Upside
AC Immune SA Competitors:
Price Targets
CENT
Central Garden & Pet Co
36% Upside
MASI
Masimo Corp
32% Upside
QNST
Quinstreet Inc
55% Upside
ONDS
Ondas Holdings Inc
1% Upside
LASR
nLIGHT Inc
-3% Downside
ZNTL
Zentalis Pharmaceuticals Inc
84% Upside
WASH
Washington Trust Bancorp Inc
5% Upside

Revenue
Forecast

-1% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
-1% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 10 years the compound annual growth rate for AC Immune SA's revenue is -1%. The projected CAGR for the next 4 years is 38%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACIU's stock price target?
Price Target
9.86 USD

According to Wall Street analysts, the average 1-year price target for ACIU is 9.86 USD with a low forecast of 8.08 USD and a high forecast of 12.6 USD.

What is AC Immune SA's Revenue forecast?
Projected CAGR
38%

For the last 10 years the compound annual growth rate for AC Immune SA's revenue is -1%. The projected CAGR for the next 4 years is 38%.

Back to Top